Home » Stocks » Uluru Inc.

Uluru Inc. (ULUR)

Stock Price: $0.710 USD 0.000 (0.00%)
Updated Aug 7, 2020 4:00 PM EDT - End of day

Stock Price Chart

Key Info

Market Cap 14.30M
Revenue (ttm) 568,744
Net Income (ttm) -2.20M
Shares Out 20.13M
EPS (ttm) -0.11
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Aug 7, 2020
Last Price $0.710
Previous Close $0.710
Change ($) 0.000
Change (%) 0.00%
Day's Open 0.710
Day's Range 0.710 - 0.710
Day's Volume 3,000
52-Week Range 0.110 - 1.200

More Stats

Market Cap 14.30M
Enterprise Value 12.32M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 20.13M
Float 6.67M
EPS (basic) n/a
EPS (diluted) -0.11
FCF / Share -0.01
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 2,034
Short Ratio 0.08
Short % of Float 0.37%
Beta -2.61
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio 25.14
PB Ratio 3.30
Revenue 568,744
Operating Income -1.80M
Net Income -2.20M
Free Cash Flow -1.79M
Net Cash 1.98M
Net Cash / Share 0.10
Gross Margin 85.71%
Operating Margin -316.94%
Profit Margin -387.30%
FCF Margin -314.90%
ROA -13.86%
ROE -40.65%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (0)

Buy 0
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: n/a

Price Target

$1,200*
Low
1,200
Current: $0.710
High
1,200
Target: 1,200
*Average 12-month price target from 1 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Year2017201620152014201320122011201020092008
Revenue0.720.440.940.860.370.370.481.560.670.73
Revenue Growth62.05%-52.7%8.32%133.12%-0.01%-23.52%-68.89%133.16%-8.93%-
Gross Profit0.490.410.660.350.150.130.281.400.630.59
Operating Income-1.74-4.30-2.44-1.70-2.64-3.26-4.01-4.14-8.53-10.10
Net Income-1.94-4.45-2.70-1.94-3.08-3.53-4.07-5.03-9.23-9.78
Shares Outstanding12556.6825.9023.6414.778.496.075.444.484.25
Earnings Per Share-0.02-0.08-0.10-0.08-0.21-0.42-0.67-0.93-2.10-2.25
Operating Cash Flow-2.20-1.56-2.08-1.06-1.73-0.96-1.69-2.70-6.89-6.01
Capital Expenditures---0.01-0.03-0.03-0.06---0.01-0.45
Free Cash Flow-2.20-1.56-2.09-1.09-1.77-1.02-1.69-2.70-6.90-6.46
Cash & Equivalents3.730.050.200.570.020.040.060.661.957.59
Total Debt0.570.020.32-1.151.840.23---
Net Cash / Debt3.160.03-0.120.57-1.12-1.80-0.170.661.957.59
Assets8.544.347.435.465.907.337.069.0213.3821.13
Liabilities2.442.773.232.714.175.482.961.612.203.60
Book Value6.111.574.202.751.731.854.107.4111.1817.53
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name Uluru Inc.
Country United States
Employees 2
CEO Vaidehi Shah

Stock Information

Ticker Symbol ULUR
Stock Exchange US OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Unique Identifier OTCMKTS: ULUR

Description

ULURU Inc., a specialty medical technology company, researches, develops, and commercializes a range of wound care and muco-adhesive film products based on its patented Nanoflex and OraDisc technologies in the United States and internationally. The company provides Altrazeal, a transforming powder dressing that is used for the treatment of various wounds, such as partial thickness burns, donor sites, and surgical and traumatic wounds, as well as chronic wounds, including diabetic foot, venous leg, and pressure ulcers. Its products also include Aphthasol paste for the treatment of canker sores; OraDisc A for canker sores; and OraDisc B, which is used for the treatment and management of oral pain. ULURU Inc. and is headquartered in Addison, Texas.